Consumer safety notice Home Hikma Products Product updates Quickfinder Hikma Products Product updates Anesthetics Anti-histamines Anti-infectives Cardiovascular and diabetes Central nervous system Gastroenterology and metabolism Musculoskeletal system Dermatology Genitourinary system Hormones Oncology Respiratory system Transplantation Vitamins and supplements Miscellaneous Keep yourself updated about Hikma Stay informed Contact our representatives Show updates about: Transplantation Anti-Infectives Cardiovascular and Diabetes Central Nervous System Product updates archive: 2010 2009 Latest Hikma news Hikma Meet the Management Day London All Hikma news Product updates Hikma enters partnership with Eisai for distribution of first-in-class epilepsy treatment Fycompa® in Middle East London, 13 October 2014– Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today announces a partnership with Eisai Co., Ltd. (“Eisai”) for the distribution of Fycompa® (perampanel), Eisai’s first-in-class epilepsy treatment, in the Middle East. The partnership will commence immediately, with perampanel launches throughout the region expected to follow in 2015. Perampanel is indicated for the adjunctive treatment of partial onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.i Continue Reading | Posted by admin, October 13, 2014 Tweet + more Hikma receives approval for colchicine 0.6mg capsules London, 30 September 2014 – Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today announces the approval of its New Drug Application (NDA) for colchicine 0.6mg capsules by the US Food and Drug Administration (FDA). Continue Reading | Posted by admin, September 30, 2014 Tweet + more Contact us Stay informed Site map Terms and conditions Disclaimer Privacy policy Cookies policy © Hikma Pharmaceuticals PLC 2014